Morphoproteomic confirmation of a constitutively activated mTOR pathway in high grade prostatic intraepithelial neoplasia and prostate cancer.
Preclinical studies have implicated the mammalian target of rapamycin (mTOR) pathway in the cell cycle progression and growth of prostate cancer cells. Downstream signaling from PI3'-K/Akt leads to phosphorylation (p) of mTOR at serine 2448 and to activation of its substrate, p70S6Kinase (p70S6K), phosphorylated on threonine 389. This promotes translation and cell cycle progression. Morphoproteomic analysis, that combines both the application of phosphospecific probes directed against putative sites of activation on protein analytes and cellular compartmentalization [1] was carried out on tissue microarray (TMA) slides from 64 cases of primary, previously untreated adenocarcinomas of the prostate. Gleason scores ranged from 6 to 10. High grade prostatic intraepithelial neoplasia (HGPIN), which accompanied the invasive cancer in 20 cases, and 15 non-neoplastic controls from benign prostatic hypertrophy specimens in a separate TMA were also included. Ninety-three percent (93%) of tumors exhibited moderate to strong cytoplasmic/plasmalemmal expression of p-mTOR and eighty-five percent (85%) showed similar staining intensity for p-p70S6K. HGPIN demonstrated comparable and occasionally, stronger expression levels for these protein analytes. Quantitative digital imaging revealed an overall increase in the mean expression levels in HGPIN, reaching statistical significance for p-mTOR (Ser 2448) at p<0.05. Morphoproteomic analysis confirms the constitutive activation of the mTOR pathway in prostate cancer and HGPIN, with relative overexpression of p-mTOR in HGPIN. These findings coincide with preclinical studies in supporting a role for the mTOR pathway in the biology and development of prostate cancer through its putative precursor lesion, HGPIN and in suggesting a potential therapeutic target.
Brown
Robert E
RE
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center - Medical School at Houston, Houston, TX, USA. robert.brown@uth.tmc.edu
Zotalis
George
G
Zhang
Ping L
PL
Zhao
Bihong
B
Int J Oncol. 2004 Apr;24(4):893-900
15010827
FEBS Lett. 1997 Dec 1;418(3):327-32
9428738
J Biol Chem. 1998 Jun 26;273(26):16621-9
9632736
Curr Mol Med. 2005 Nov;5(7):653-61
16305491
Cancer Res. 2006 Aug 1;66(15):7783-92
16885382
Zhonghua Nan Ke Xue. 2006 Jan;12(1):57-9
16483162
J Biol Chem. 1996 Jan 12;271(2):963-71
8557712
EMBO J. 1994 Apr 1;13(7):1557-65
8156994
Nat Clin Pract Urol. 2007 Jun;4(6):321-32
17551536
Semin Cancer Biol. 1994 Aug;5(4):255-60
7803761
Hum Pathol. 2005 Nov;36(11):1186-96
16260272
Vojnosanit Pregl. 2007 May;64(5):325-30
17585548
Circ Res. 2004 May 14;94(9):1186-94
15059936
Clin Cancer Res. 2004 Oct 1;10(19):6572-8
15475446
Biochem Biophys Res Commun. 1997 May 29;234(3):681-5
9175775
Med Hypotheses. 2008;70(2):387-408
17658698
Biochem J. 1999 Dec 1;344 Pt 2:427-31
10567225
J Biol Chem. 2000 Aug 18;275(33):25451-9
10846175
Science. 1998 Jan 30;279(5351):707-10
9445476
J Biol Chem. 2004 Jan 9;279(2):1010-9
14581487
Crit Rev Biochem Mol Biol. 1994;29(6):385-413
7705100
J Urol. 1999 Oct;162(4):1537-42
10492251
Ann Clin Lab Sci. 2006 Summer;36(3):283-93
16951269
Clin Cancer Res. 2002 Apr;8(4):1168-71
11948129
Expert Rev Proteomics. 2005 Jun;2(3):337-48
16000081
Cancer Res. 2005 Nov 1;65(21):9953-61
16267020
Nat Med. 2004 Jun;10(6):594-601
15156201
Hum Pathol. 1998 Jul;29(7):668-75
9670822
Prostate. 2006 Aug 1;66(11):1203-12
16652388
J Urol. 2004 Oct;172(4 Pt 1):1333-7
15371835
Mol Cell Biol. 1996 Nov;16(11):6242-51
8887654
Prostate. 1996 Nov;29(5):282-6
8899000
Mol Endocrinol. 2005 Jan;19(1):102-12
15388791
Am J Physiol Cell Physiol. 2004 Aug;287(2):C281-91
15028555
J Biol Chem. 2005 May 20;280(20):19445-8
15809305
Cancer Res. 2005 Apr 1;65(7):2825-31
15805283
Ann Clin Lab Sci. 2006 Summer;36(3):273-82
16951268
Biochem Biophys Res Commun. 2003 Oct 31;310(4):1124-32
14559232
Endocrinology. 1999 Oct;140(10):4659-68
10499523
J Biol Chem. 2002 Mar 29;277(13):11591-6
11799119
Mod Pathol. 1994 Jun;7(5):549-54
7524068
Cancer Genet Cytogenet. 2006 Sep;169(2):128-37
16938570
Anticancer Res. 2006 Jul-Aug;26(4B):2989-93
16886625
Mod Pathol. 1996 Oct;9(10):1015-9
8902840